Carlos Romo
Overview
Explore the profile of Carlos Romo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
40
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jiang K, Kalluri A, Odonkor M, Heinemann D, Weber-Levine C, Raj D, et al.
World Neurosurg
. 2025 Feb;
196:123716.
PMID: 39947316
Objective: Oligodendrogliomas present challenges in management despite their favorable prognosis. Optimal therapeutic strategies are not well-established. We aimed to characterize current practice patterns and identify areas of discordance in oligodendroglioma...
2.
Lau J, Fleming J, Good M, Lim A, Saunderson R, Phan T, et al.
Skin Res Technol
. 2024 Sep;
30(9):e70020.
PMID: 39225289
Background: Cutaneous neurofibromas (cNFs) are a major cause of disfigurement in patients with Neurofibromatosis Type 1 (NF1). However, clinical trials investigating cNF treatments lack standardised outcome measures to objectively evaluate...
3.
Debs P, Belzberg A, Blakeley J, Fayad L, Langmead S, Little E, et al.
Skeletal Radiol
. 2023 Nov;
53(5):909-916.
PMID: 37950060
Objective: To evaluate the role of weekly neurofibromatosis (NF) multi-disciplinary conferences (MDC) on the diagnostic and therapeutic plan for patients with NF type 1 (NF1) and schwannomatosis (SWN). Materials And...
4.
Wilson A, Jung Y, Mooneyham S, Klymko I, Eck J, Romo C, et al.
Front Public Health
. 2023 Oct;
11:1181047.
PMID: 37780432
Introduction: Cleaning protocols were changed in response to the COVID-19 pandemic with unknown occupational health impacts. There is evidence that COVID-19 transmission risks from contaminated surfaces are low and that...
5.
Gummerson C, Lo B, Porosnicu Rodriguez K, Cosner Z, Hardenbergh D, Bongiorno D, et al.
BMC Med Educ
. 2021 Oct;
21(1):549.
PMID: 34715841
Background: In response to the cancellation of clinical clerkships due to COVID-19, the Johns Hopkins (JH) Neurology Education Team developed a virtual elective to enhance medical students' clinical telemedicine skills...
6.
Nazha A, Kantarjian H, Jain P, Romo C, Jabbour E, Quintas-Cardama A, et al.
Haematologica
. 2013 Jul;
98(11):1686-8.
PMID: 23812943
Response to tyrosine kinase inhibitors at three months is a predictor for long-term outcome in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors. We analyzed 456 newly diagnosed chronic...
7.
Carrancio S, Blanco B, Romo C, Muntion S, Lopez-Holgado N, Blanco J, et al.
PLoS One
. 2011 Oct;
6(10):e26241.
PMID: 22028841
The aim of the present study was to determine how mesenchymal stem cells (MSC) could improve bone marrow (BM) stroma function after damage, both in vitro and in vivo. Human...